PHIO · Phio Pharmaceuticals Corp. Common Stock
View on chartInsiders & Stakes
| Robert J. Bitterman Chairman, Pres. & CEO | ▲ Buy | Grant | 764,871 Shares held | 9/28/2026 | View profile |
| Dispersyn Gerrit President & CEO | ▼ Sell | Tax Withholding | 212,327 Shares held | 3/1/2022 | View profile |
| Lisa Cabott Carson Chief Financial Officer | ▲ Buy | Grant | 189,112 Shares held | 9/28/2026 | View profile |
| Patricia A. Bradford Director | ▲ Buy | Open Market | 64,151 Shares held | 9/24/2026 | View profile |
| Plott Ronald Todd Director | ▲ Buy | Open Market | 42,000 Shares held | 9/29/2026 | View profile |
| Robert L. Ferrara Director | ▲ Buy | Grant | 38,666 Shares held | 9/11/2025 | View profile |
| David H. Deming Director | ▲ Buy | Grant | 37,800 Shares held | 2/5/2026 | View profile |
| Curtis Lockshin Director | ▲ Buy | Grant | 35,155 Shares held | 2/5/2026 | View profile |
| Jonathan E. Freeman Director | ▲ Buy | Grant | 32,655 Shares held | 2/5/2026 | View profile |
| Dorman H. Paul Director | ▲ Buy | Grant | 20,370 Shares held | 2/15/2022 | View profile |
| Robert M. Infarinato VP, Chief Financial Officer | ▲ Buy | Grant | 11,000 Shares held | 9/11/2024 | View profile |
| Caitlin Kontulis Secretary & VP Finance & Admin | ▼ Sell | Tax Withholding | 10,643 Shares held | 3/1/2024 | View profile |
| CAUWENBERGH GEERT Director | ▲ Buy | Grant | 4,235 Shares held | 2/17/2023 | View profile |
Transaction History
| Plott Ronald Todd | ▲ Buy | Open Market | 5,000 | $5K | 9/29/2026 |
| Plott Ronald Todd | ▲ Buy | Open Market | 5,000 | $5K | 9/28/2026 |
| Lisa Cabott Carson | ▲ Buy | Grant | 108,000 | $0 | 9/28/2026 |
| Robert J. Bitterman | ▲ Buy | Grant | 400,000 | $0 | 9/28/2026 |
| Plott Ronald Todd | ▲ Buy | Grant | 17,000 | $0 | 9/28/2026 |
| Patricia A. Bradford | ▲ Buy | Open Market | 6,500 | $7K | 9/24/2026 |
| Robert J. Bitterman | ▲ Buy | Open Market | 2,000 | $2K | 9/22/2026 |
| Patricia A. Bradford | ▲ Buy | Open Market | 12,000 | $12K | 9/15/2026 |
| Lisa Cabott Carson | ▼ Sell | Tax Withholding | 12,888 | $13K | 9/11/2026 |
| Robert J. Bitterman | ▼ Sell | Tax Withholding | 68,550 | $71K | 9/11/2026 |
| Plott Ronald Todd | ▲ Buy | Open Market | 15,000 | $17K | 8/19/2026 |
| Robert J. Bitterman | ▲ Buy | Open Market | 10,000 | $11K | 8/18/2026 |
| Robert J. Bitterman | ▲ Buy | Open Market | 10,000 | $10K | 6/26/2026 |
| David H. Deming | ▲ Buy | Grant | 23,800 | $0 | 2/5/2026 |
| Lisa Cabott Carson | ▲ Buy | Grant | 47,000 | $0 | 2/5/2026 |
| Patricia A. Bradford | ▲ Buy | Grant | 18,500 | $0 | 2/5/2026 |
| Robert J. Bitterman | ▲ Buy | Grant | 120,000 | $0 | 2/5/2026 |
| Jonathan E. Freeman | ▲ Buy | Grant | 16,600 | $0 | 2/5/2026 |
| Curtis Lockshin | ▲ Buy | Grant | 16,600 | $0 | 2/5/2026 |
| Robert J. Bitterman | ▲ Buy | Open Market | 5,000 | $5K | 12/31/2025 |
| Robert J. Bitterman | ▲ Buy | Open Market | 5,000 | $5K | 12/23/2025 |
| Robert J. Bitterman | ▲ Buy | Open Market | 5,000 | $6K | 11/21/2025 |
| Robert J. Bitterman | ▲ Buy | Open Market | 5,000 | $6K | 11/18/2025 |
| Robert J. Bitterman | ▼ Sell | Tax Withholding | 4,111 | $10K | 9/11/2025 |
| David H. Deming | ▲ Buy | Grant | 14,000 | $0 | 9/11/2025 |
| Curtis Lockshin | ▲ Buy | Grant | 16,200 | $0 | 9/11/2025 |
| Jonathan E. Freeman | ▲ Buy | Grant | 14,700 | $0 | 9/11/2025 |
| Robert L. Ferrara | ▲ Buy | Grant | 23,000 | $0 | 9/11/2025 |
| Lisa Cabott Carson | ▲ Buy | Grant | 47,000 | $0 | 9/11/2025 |
| Patricia A. Bradford | ▲ Buy | Grant | 18,800 | $0 | 9/11/2025 |
| Robert J. Bitterman | ▲ Buy | Grant | 250,000 | $0 | 9/11/2025 |
| Robert J. Bitterman | ▲ Buy | Open Market | 2,000 | $5K | 6/10/2025 |
| Robert L. Ferrara | ▲ Buy | Open Market | 2,500 | $6K | 6/10/2025 |
| Robert J. Bitterman | ▲ Buy | Open Market | 1,500 | $4K | 6/9/2025 |
| Robert J. Bitterman | ▲ Buy | Open Market | 1,200 | $2K | 5/22/2025 |
| Robert J. Bitterman | ▲ Buy | Open Market | 3,000 | $5K | 5/21/2025 |
| Robert L. Ferrara | ▲ Buy | Open Market | 2,500 | $5K | 5/20/2025 |
| Robert M. Infarinato | ▲ Buy | Grant | 3,000 | $0 | 9/11/2024 |
| Jonathan E. Freeman | ▲ Buy | Grant | 1,000 | $0 | 9/11/2024 |
| Robert J. Bitterman | ▲ Buy | Grant | 15,500 | $0 | 9/11/2024 |
| Curtis Lockshin | ▲ Buy | Grant | 2,000 | $0 | 9/11/2024 |
| Robert L. Ferrara | ▲ Buy | Grant | 10,000 | $0 | 9/11/2024 |
| Patricia A. Bradford | ▲ Buy | Grant | 8,000 | $0 | 9/11/2024 |
| Robert M. Infarinato | ▲ Buy | Grant | 8,000 | $0 | 8/13/2024 |
| Robert J. Bitterman | ▲ Buy | Open Market | 1,000 | $740 | 6/7/2024 |
| Robert J. Bitterman | ▲ Buy | Open Market | 1,000 | $750 | 6/6/2024 |
| Caitlin Kontulis | ▼ Sell | Tax Withholding | 335 | $321 | 3/1/2024 |
| Robert J. Bitterman | ▲ Buy | Open Market | 2,500 | $2K | 2/26/2024 |
| Robert J. Bitterman | ▼ Sell | Tax Withholding | 1,804 | $1K | 2/20/2024 |
| Caitlin Kontulis | ▼ Sell | Tax Withholding | 523 | $345 | 2/17/2024 |
| Caitlin Kontulis | ▼ Sell | Tax Withholding | 658 | $428 | 2/15/2024 |
| Robert J. Bitterman | ▼ Sell | Tax Withholding | 917 | $1K | 10/1/2023 |
| Robert J. Bitterman | ▲ Buy | Open Market | 1,000 | $3K | 7/1/2023 |
| Robert J. Bitterman | ▲ Buy | Open Market | 1,000 | $3K | 6/30/2023 |
| Robert L. Ferrara | ▲ Buy | Open Market | 2,000 | $6K | 6/14/2023 |
| Caitlin Kontulis | ▼ Sell | Tax Withholding | 335 | $2K | 3/1/2023 |
| Robert J. Bitterman | ▲ Buy | Grant | 11,000 | $0 | 2/20/2023 |
| Curtis Lockshin | ▲ Buy | Grant | 1,500 | $0 | 2/17/2023 |
| Jonathan E. Freeman | ▲ Buy | Grant | 1,500 | $0 | 2/17/2023 |
| Robert L. Ferrara | ▲ Buy | Grant | 1,500 | $0 | 2/17/2023 |
| CAUWENBERGH GEERT | ▲ Buy | Grant | 1,500 | $0 | 2/17/2023 |
| Patricia A. Bradford | ▲ Buy | Grant | 1,500 | $0 | 2/17/2023 |
| Caitlin Kontulis | ▲ Buy | Grant | 4,500 | $0 | 2/17/2023 |
| Caitlin Kontulis | ▼ Sell | Tax Withholding | 657 | $3K | 2/15/2023 |
| Robert J. Bitterman | ▲ Buy | Open Market | 2,000 | $780 | 12/14/2022 |
| Robert J. Bitterman | ▲ Buy | Open Market | 2,000 | $780 | 12/7/2022 |
| Robert J. Bitterman | ▲ Buy | Open Market | 2,000 | $860 | 12/5/2022 |
| Robert L. Ferrara | ▲ Buy | Open Market | 5,000 | $2K | 12/2/2022 |
| Robert J. Bitterman | ▲ Buy | Open Market | 215 | $86 | 11/29/2022 |
| Robert J. Bitterman | ▲ Buy | Open Market | 2,500 | $1K | 11/25/2022 |
| Robert L. Ferrara | ▲ Buy | Open Market | 2,000 | $820 | 11/23/2022 |
| Robert J. Bitterman | ▲ Buy | Open Market | 1 | $2K | 11/16/2022 |
| Robert J. Bitterman | ▲ Buy | Grant | 40,000 | $0 | 10/1/2022 |
| Patricia A. Bradford | ▲ Buy | Grant | 20,000 | $0 | 8/9/2022 |
| Caitlin Kontulis | ▼ Sell | Tax Withholding | 4,011 | $3K | 3/1/2022 |
| Dispersyn Gerrit | ▼ Sell | Tax Withholding | 8,954 | $7K | 3/1/2022 |
| Curtis Lockshin | ▲ Buy | Grant | 10,000 | $0 | 2/15/2022 |
| Caitlin Kontulis | ▲ Buy | Grant | 68,000 | $0 | 2/15/2022 |
| Jonathan E. Freeman | ▲ Buy | Grant | 10,000 | $0 | 2/15/2022 |
| Robert L. Ferrara | ▲ Buy | Grant | 10,000 | $0 | 2/15/2022 |
| Dorman H. Paul | ▲ Buy | Grant | 10,000 | $0 | 2/15/2022 |
| Robert J. Bitterman | ▲ Buy | Grant | 10,000 | $0 | 2/15/2022 |
| Dispersyn Gerrit | ▲ Buy | Grant | 126,000 | $0 | 2/15/2022 |
| CAUWENBERGH GEERT | ▲ Buy | Grant | 10,000 | $0 | 2/15/2022 |
| Dispersyn Gerrit | ▲ Buy | Open Market | 6,000 | $10K | 8/16/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
PHIO to Speak at NIBA Conference as OTC Markets Announces Forum
Phio Pharmaceuticals will present at the National Investment Banking Association’s 153rd conference. The presentation gives the company a chance to share updates with investors. At the same time, OTC Markets Group released the agenda for its third annual Global Markets Forum, an event that could influence activity on the OTC market where PHIO trades.
PHIO to Speak at NIBA Conference as OTC Markets Announces Forum. Phio Pharmaceuticals will present at the National Investment Banking Association’s 153rd conference. The presentation gives the company a chance to share updates with investors. At the same time, OTC Markets Group released the agenda for its third annual Global Markets Forum, an event that could influence activity on the OTC market where PHIO trades.